We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » ELI LILLY, GENERICS SET TO BATTLE OVER ZYPREXA PATENT
ELI LILLY, GENERICS SET TO BATTLE OVER ZYPREXA PATENT
January 23, 2004
Generic drugmakers Ivax and Dr. Reddy’s are scheduled today to start challenging a patent on drugmaker Eli Lilly’s top-selling schizophrenia drug Zyprexa (olanzapine).